Drug Sponsors

Galectin to relocate headquarters to Atlanta

Friday, August 31, 2012 01:28 PM

Galectin Therapeutics, a developer of therapeutics that target galectin proteins to treat fibrosis and cancer, will be relocating its corporate offices to Atlanta, Ga., effective October 1, 2012, while maintaining a laboratory-based effort in the Boston area.

More... »

Aerpio completes $27M Series A Financing for diabetic macular edema

Thursday, August 30, 2012 02:07 PM

Aerpio Therapeutics, a clinical-stage biopharmaceutical spin off of Akebia Therapeutics based in Cincinnati, Ohio, has closed a $27 million Series A financing.

More... »

Sunovion to acquire Elevation Pharma

Thursday, August 30, 2012 01:42 PM

Sunovion Pharmaceuticals, a Marlborough, Mass.-based pharmaceutical company focused on the central nervous system and respiratory disease, has agreed to acquire San Diego-based Elevation Pharmaceuticals, which specializes in the development of new aerosol therapies for patients with respiratory diseases.

More... »

Oncologists restrict pharmaceutical sales rep access at accelerating rates

Wednesday, August 29, 2012 01:37 PM

As more pharmaceutical companies prepare to bring new oncology drugs to market, their sales representatives face a rising hurdle—oncologists are reducing the number of times they will see them.

More... »

Novira secures $23M Series A financing for Hep B, HIV

Wednesday, August 29, 2012 11:12 AM

Novira Therapeutics, an antiviral drug discovery company, has secured $23 million in Series A financing to support the development of its capsid-targeting antivirals for the treatment of chronic hepatitis B (HBV) and HIV infections.

More... »

Oxygen Biotherapeutics relocating R&D function to North Carolina

Wednesday, August 29, 2012 10:04 AM

Oxygen Biotherapeutics, a Morrisville, N.C.-based developer of medical and cosmetic products that efficiently deliver oxygen to tissues in the body, is searching for laboratory space in the Research Triangle Park region of North Carolina.

More... »

Pascal Soriot named AstraZeneca CEO

Tuesday, August 28, 2012 03:06 PM

AstraZeneca has announced Pascal Soriot’s appointment as the company’s chief executive officer. He will assume the new role and join the AstraZeneca board as an executive director as of Oct. 1.

More... »

Alnylam and Monsanto form strategic alliance

Tuesday, August 28, 2012 02:51 PM

St. Louis-based Monsanto and Alnylam Pharmaceuticals of Cambridge, Mass., have formed a strategic alliance to advance biological technologies in the field of agriculture. The new alliance brings Alnylam's broad RNAi-based intellectual property (IP) and proprietary technologies to Monsanto's new BioDirect technology, which aims to deliver innovative biological solutions for farmers.

More... »

Pristine Solutions acquires Eaton Scientific Systems

Monday, August 27, 2012 12:08 PM

Pristine Solutions has completed the acquisition of Eaton Scientific Systems, a biomedical product development company focused on women's health solutions.

More... »

Agennix announces corporate restructuring

Friday, August 24, 2012 02:48 PM

Agennix has announced a restructuring that involves staff reductions of approximately 55% of the company's workforce. The restructuring is being implemented to conserve cash as management determines the company’s next strategic steps.

More... »